New data supporting modified RECIST (mRECIST) for hepatocellular carcinoma

Riccardo Lencioni

Research output: Contribution to journalArticlepeer-review

68 Scopus citations


The modified Response Evaluation Criteria in Solid Tumors (mRECIST) guideline has introduced specific amendments to standard RECIST to address the unique complexities involved in the evaluation of tumor response in hepatocellular carcinoma. A growing amount of data suggests that mRECIST, designed for response assessment in clinical trials, may translate into a tool for clinical practice.

Original languageEnglish (US)
Pages (from-to)1312-1314
Number of pages3
JournalClinical Cancer Research
Issue number6
StatePublished - Mar 15 2013

ASJC Scopus subject areas

  • Oncology
  • Cancer Research


Dive into the research topics of 'New data supporting modified RECIST (mRECIST) for hepatocellular carcinoma'. Together they form a unique fingerprint.

Cite this